Literature DB >> 27739050

Optimizing Chemotherapeutic Anti-cancer Treatment and the Tumor Microenvironment: An Analysis of Mathematical Models.

Urszula Ledzewicz1,2, Heinz Schaettler3.   

Abstract

We review results about the structure of administration of chemotherapeutic anti-cancer treatment that we have obtained from an analysis of minimally parameterized mathematical models using methods of optimal control. This is a branch of continuous-time optimization that studies the minimization of a performance criterion imposed on an underlying dynamical system subject to constraints. The scheduling of anti-cancer treatments has all the features of such a problem: treatments are administered in time and the interactions of the drugs with the tumor and its microenvironment determine the efficacy of therapy. At the same time, constraints on the toxicity of the treatments need to be taken into account. The models we consider are low-dimensional and do not include more refined details, but they capture the essence of the underlying biology and our results give robust and rather conclusive qualitative information about the administration of optimal treatment protocols that strongly correlate with approaches taken in medical practice. We describe the changes that arise in optimal administration schedules as the mathematical models are increasingly refined to progress from models that only consider the cancerous cells to models that include the major components of the tumor microenvironment, namely the tumor vasculature and tumor-immune system interactions.

Entities:  

Keywords:  Anti-angiogenic therapy; Mathematical modeling; Metronomic chemotherapy; Optimal control; Optimization of cancer treatments; Tumor immune system interactions; Tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27739050     DOI: 10.1007/978-3-319-42023-3_11

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Systems biology: perspectives on multiscale modeling in research on endocrine-related cancers.

Authors:  Robert Clarke; John J Tyson; Ming Tan; William T Baumann; Lu Jin; Jianhua Xuan; Yue Wang
Journal:  Endocr Relat Cancer       Date:  2019-06       Impact factor: 5.678

2.  Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide.

Authors:  Xin-Jun Cai; Wei-Dong Fei; Ying-Ying Xu; Hong Xu; Gao-Yi Yang; Jia-Wei Cao; Jian-Jun Ni; Zeng Wang
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 3.  The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer.

Authors:  Benjamin Wölfl; Hedy Te Rietmole; Monica Salvioli; Artem Kaznatcheev; Frank Thuijsman; Joel S Brown; Boudewijn Burgering; Kateřina Staňková
Journal:  Dyn Games Appl       Date:  2021-08-30       Impact factor: 1.296

4.  Impact of Cisplatin Dosing Regimens on Mammary Tumor Growth in an Animal Model.

Authors:  James A Koziol; Theresa J Falls; Jan E Schnitzer
Journal:  Arch Cancer Biol Ther       Date:  2020-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.